Umami Bioworks Overview

  • Year Founded
  • 2020

Year Founded

  • Status
  • Private

  • Employees
  • 44

Employees

  • Latest Deal Type
  • Accelerator/​Inc

  • Latest Deal Amount
  • $250K

  • Investors
  • 43

Umami Bioworks General Information

Description

Producer of cell-based food products intended to offer a healthy alternative to seafood. The company's products are directly made from fish cells and tissue and are free from mercury, antibiotics, microplastics, and ocean pollutants, enabling customers to find affordable, cell-cultured seafood and meat with low-cost, serum-free media and novel marine cell lines.

Contact Information

Formerly Known As
Umami Meats
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 89 Science Park Drive
  • Level 04, Unit Number 22
  • Singapore, 118261
  • Singapore
Primary Industry
Food Products
Other Industries
Aquaculture
Corporate Office
  • 89 Science Park Drive
  • Level 04, Unit Number 22
  • Singapore, 118261
  • Singapore

Umami Bioworks Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Umami Bioworks Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
15. Accelerator/Incubator 04-Jun-2026 $250K Completed Generating Revenue
14. Later Stage VC 01-Feb-2026 Completed Generating Revenue
13. Secondary Transaction - Private Completed Generating Revenue
12. Accelerator/Incubator 10-Feb-2025 Completed Generating Revenue
11. Early Stage VC (Series A) 15-Sep-2024 Completed Generating Revenue
10. Seed Round 30-Aug-2023 Completed Generating Revenue
9. Accelerator/Incubator 01-Jan-2023 Completed Generating Revenue
8. Accelerator/Incubator 17-Jun-2022 Completed Generating Revenue
7. Seed Round 01-Mar-2022 $2.4M $3.9M Completed Generating Revenue
6. Accelerator/Incubator 01-Jan-2022 $1.5M Completed Generating Revenue
To view Umami Bioworks’s complete valuation and funding history, request access »

Umami Bioworks Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A Shares
To view Umami Bioworks’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Umami Bioworks Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Producer of cell-based food products intended to offer a healthy alternative to seafood. The company's products are dire
Food Products
Singapore, Singapore
44 As of 2026

Hong Kong, Hong Kong
 

Rehovot, Israel
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Umami Bioworks Competitors (14)

One of Umami Bioworks’s 14 competitors is Avant (Aquaculture), a Venture Capital-Backed company based in Hong Kong, Hong Kong.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Avant (Aquaculture) Venture Capital-Backed Hong Kong, Hong Kong
Aleph Farms Venture Capital-Backed Rehovot, Israel
Meatiply Venture Capital-Backed Singapore, Singapore
Impossible Foods Venture Capital-Backed Redwood City, CA
BlueNalu Venture Capital-Backed San Diego, CA
You’re viewing 5 of 14 competitors. Get the full list »

Umami Bioworks Patents

Umami Bioworks Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026088079-A1 Generation of co-products from animal cell cultivation waste streams Pending 21-Oct-2024
WO-2025126155-A1 Compositions and methods for production of edible cell-infused scaffolds Inactive 14-Dec-2023

Umami Bioworks Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Umami Bioworks Investors (43)

Investor Name Investor Type Holding Investor Since Participating Rounds
Hub71 Accelerator/Incubator
Agronomics Venture Capital Minority
n22 Venture Capital Minority
Unleashed Accelerator Accelerator/Incubator Minority
AiiM Partners Venture Capital Minority
You’re viewing 5 of 43 investors. Get the full list »

Umami Bioworks Acquisitions (1)

Umami Bioworks’s most recent deal was a Merger/Acquisition with Shiok Meats. The deal was made on 12-Mar-2024.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Shiok Meats 12-Mar-2024 Merger/Acquisition Food Products
To view Umami Bioworks’s complete acquisitions history, request access »

Umami Bioworks FAQs

  • When was Umami Bioworks founded?

    Umami Bioworks was founded in 2020.

  • Where is Umami Bioworks headquartered?

    Umami Bioworks is headquartered in Singapore, Singapore.

  • What is the size of Umami Bioworks?

    Umami Bioworks has 44 total employees.

  • What industry is Umami Bioworks in?

    Umami Bioworks’s primary industry is Food Products.

  • Is Umami Bioworks a private or public company?

    Umami Bioworks is a Private company.

  • What is Umami Bioworks’s current revenue?

    The current revenue for Umami Bioworks is .

  • How much funding has Umami Bioworks raised over time?

    Umami Bioworks has raised $34.4M.

  • Who are Umami Bioworks’s investors?

    Hub71, Agronomics, n22, Unleashed Accelerator, and AiiM Partners are 5 of 43 investors who have invested in Umami Bioworks.

  • Who are Umami Bioworks’s competitors?

    Avant (Aquaculture), Aleph Farms, Meatiply, Impossible Foods, and BlueNalu are some of the 14 competitors of Umami Bioworks.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process